Needle Free Diabetes Care Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2026

Category: Healthcare Report Format : PDF Report Code: ZMR-6016 Status : Upcoming

Description

Global Needle Free Diabetes Care Market: Overview

Diabetes is a disorder caused by insulin deficiency. Needle-free diabetes care is an innovative technique for the administration of diabetic drugs to patients. Diabetic patients check their sugar levels many times a day by using lancet by pricking their fingers in it. It is a very uncomfortable and painful way of checking sugar levels in the human body and thus people are less frequent to check & monitor their sugar levels at regular intervals. Hence, millions of people across the globe have started using needle-free diabetic care to monitor and manage their diabetes.

Global Needle Free Diabetes Care Market: Growth Factors

Insulin is known to be the first-line treatment for diabetic patients when their bodies do not respond to oral hypoglycemic medications. Insulin is injected into their body via intravenous and subcutaneous injections. Pricking of blood vessels is the most common way of diagnosing diabetes, which causes needle stick damages in patients and inconvenience for healthcare specialists too. As a result, the patient suffers from pain and infections. Diabetes needs a constant draw of blood for glucose testing. Hence, it needs to be monitored on a daily basis, which in turn leads to the continuous poking of blood vessels at regular intervals. It increases the probability of infections and pain in the patient’s body. Thus, the demand for needle-free diabetic care is increasing significantly during the forecast period. These days, insulin pumps and glucose monitors are widely available for automating the testing of blood glucose level and its management. But, they do not eliminate the use of a needle for skin shots and pricks. Thus, the needle-free diabetes care air is a non-invasive technology that is gaining extensive popularity worldwide. One of the major factors driving the growth of the global needle free diabetes care market is the constantly growing aging population along with a high prevalence of diabetic disease all across the globe. Moreover, the growth of obesity, transforming food habits, and modern lifestyle will further contribute significantly to the growth of the global needle free diabetes care market during the forecast period.

Global Needle Free Diabetes Care Market: Segmentation

The global needle free diabetes care market can be segmented into device, end-user, treatment, application, and region.

By device, the market can be segmented into diagnostic and treatment devices. The treatment devices can further be segmented into insulin patch & pump, insulin inhaler, insulin pen, and insulin jet injector. The diagnostic devices can further be segmented into instant glucose monitoring and continuous glucose monitoring.

By end-user, the market can be segmented into consumers, diagnostic centers, clinics, and hospitals.

By treatment, the market can be segmented into insulin patches, inhaled insulin, oral insulin, and others.

By application, the market can be segmented into insulin delivery and others.

Global Needle Free Diabetes Care Market: Regional analysis

North America accounts for the largest share in the global needle free diabetes care market due to the early adoption of technology and the growing aging population in the region. The presence of prominent key players in the region is further fuelling the growth of the regional market.

Asia Pacific accounts for the second-largest share in the global needle free diabetes care market owing to the growing diabetic population in the region. Moreover, the growing funding to boost the research & development activities in the field of diabetes care and increasing awareness among the population to adopt needle-free diabetes self-care is further fuelling the growth of the regional market.

Global Needle Free Diabetes Care Market: Competitive Players

Some of the significant players in the global needle free diabetes care market are Pancreum LLC, Johnson and Johnson, Inc., Medtronic, Inc., National Medical Products Inc., Bioject Medical Technologies, Inc., Pharmajet, Inc., Injex Pharma AG, Glide Pharmaceutical Technologies Ltd., Antares Pharma Inc., 3M, Zogenix, Inc., Medical International Technology, Inc., MannKind Corporation, European Pharma Group BV, Echo Therapeutics Inc., and Akra Dermojet.

Global Needle Free Diabetes Care Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content


Frequently Asked Questions

Diabetes needs a constant draw of blood for glucose testing. Hence, it needs to be monitored on a daily basis, which in turn leads to the continuous poking of blood vessels at regular intervals. It increases the probability of infections and pain in the patient’s body. Thus, the demand for needle-free diabetic care is increasing significantly during the forecast period. Moreover, the growth of obesity, transforming food habits, and modern lifestyle will further contribute significantly to the growth of the global needle free diabetes care market during the forecast period.

Some of the significant players in the global needle free diabetes care market are Pancreum LLC, Johnson and Johnson, Inc., Medtronic, Inc., National Medical Products Inc., Bioject Medical Technologies, Inc., Pharmajet, Inc., Injex Pharma AG, Glide Pharmaceutical Technologies Ltd.

North America accounts for the largest share in the global needle free diabetes care market due to the early adoption of technology and the growing aging population in the region. The presence of prominent key players in the region is further fuelling the growth of the regional market.

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com